LQDA Q2 2018 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena

LQDALiquidia Corporation

$3B

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-47.4% YoY

Gross Profit

$948,53791.0% margin

Operating Income

-$7M-667.4% margin

Net Income

-$6M-601.1% margin

EPS (Diluted)

$-0.41

QoQ Revenue Growth

+12.6%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$8M

Stock-Based Comp.

$519,835

Balance Sheet

Total Assets

$21M

Total Liabilities

$34M

Stockholders' Equity

-$13M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$2M	-47.4%
Gross Profit	$948,537	$2M	-50.1%
Operating Income	-$7M	-$6M	-10.8%
Net Income	-$6M	-$8M	+24.4%

Revenue Segments

Collaboration And Licensing Non Refundable Upfront Payments

$943,41987%

Research And Development Services

$99,4609%

Collaboration And Licensing Milestones

$45,0584%